循環器ジャーナル68巻3号

2020年07月発行

特集 不整脈治療の最新デバイステクノロジーとリードマネジメント Ⅴ．遠隔モニタリング

遠隔管理を用いた心不全管理

著者： 奥山貴文¹ 今井靖¹

所属機関： ¹自治医科大学内科学講座循環器内科学部門

ページ範囲：P.550 - P.557

Point
・胸郭インピーダンスを含めた多面的な情報収集により，心不全増悪の早期発見が可能となる．
・外来通院回数の軽減や診察時間の短縮につながり，患者負担を軽減することができる．
・実臨床での有効性が示され，日本循環器学会にてClass Ⅱaで推奨されている．

参考文献

1) 日本循環器学会：循環器疾患診療実態調査報告書（2016年度実施．公表）．2016　http://www.j-circ.or.jp/jittai_chosa/jittai_chosa2015web.pdf

2) Okura Y, Ramadan MM, Ohno Y, et al:Impending epidemic:future projection of heart failure in Japan to the year 2055. Circ J 72:489-491, 2008

3) Inglis SC, Clark RA, Dierckx R, et al:Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev 31:CD007228, 2015

4) Bayés de Luna A, Coumel P, Leclercq JF:Ambulatory sudden cardiac death:mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117:151-159, 1989

5) MERIT-HF Study Group:Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure（MERIT-HF）. Lancet 353:2001-2007, 1999

6) Yu CM, Wang L, Chau E, et al:Intrathoracic impedance monitoring in patients with heart failure:correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112:841-848, 2005

7) Lüthje L, Vollmann D, Drescher T, et al:Intrathoracic impedance monitoring to detect chronic heart failure deterioration:relationship to changes in NT-proBNP. Eur J Heart Fail 9:716-722, 2007

8) Conraads VM, Tavazzi L, Santini M, et al:Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations:the SENSE-HF trial. Eur Heart J 32:2266-2273, 2011

9) van Veldhuisen DJ, Braunschweig F, Conraads V, et al:Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124:1719-1726, 2011

10) Hindricks G, Taborsky M, Glikson M, et al:IN-TIME study group. Implant-based multiparameter telemonitoring of patients with heartfailure（IN-TIME）:a randomised controlled trial. Lancet 384:583-590, 2014

11) Saxon LA, Hayes DL, Gilliam FR, et al:Long-term outcome after ICD and CRT implantation and influence of remote device follow-up:the ALTITUDE survival study. Circulation 122:2359-2367, 2010

12) Boehmer JP, Hariharan R, Devecchi FG, et al:A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices:Results From the MultiSENSE Study. JACC Heart Fail 5:216-225, 2017

13) Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, et al:Clinical characteristics and outcome of hospitalized patients with heart failure in Japan. Circ J 70:1617-1623, 2006

14) Shiba N, Watanabe J, Shinozaki T, et al:Analysis of chronic heart failure registry in the Tohoku district:third year follow-up. Circ J 68:427-434, 2004

15) Shiba N, Nochioka K, Miura M, et al:Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan—first report from the CHART-2 study—. Circ J 75:823-833, 2011

16) Poole JE, Johnson GW, Hellkamp AS, et al:Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009-1017, 2008

17) Hayes DL, Boehmer JP, Day JD, et al:Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8:1469-1475, 2011

18) Gasparini M, Auricchio A, Metra M, et al:Long-term survival in patients undergoing cardiac resynchronization therapy:the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 29:1644-1652, 2008

19) Abraham WT, Adamson PB, Bourge RC, et al:Wireless pulmonary artery haemodynamic monitoring in chronic heart failure:a randomised controlled trial. Lancet 377:658-666, 2011